Total Payments
$4,590
2023 Payments
$736.10
Companies
17
Transactions
45
Medicare Patients
1,450
Medicare Billing
$170,951
Payment Breakdown by Category
Food & Beverage$4,590 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,590 | 45 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,543 | 13 | $0 (2023) |
| AbbVie, Inc. | $932.96 | 10 | $0 (2019) |
| Daiichi Sankyo Inc. | $362.40 | 3 | $0 (2019) |
| Amgen Inc. | $333.01 | 3 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $239.32 | 3 | $0 (2019) |
| Grifols USA, LLC | $125.70 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $125.00 | 1 | $0 (2018) |
| GlaxoSmithKline, LLC. | $121.71 | 1 | $0 (2023) |
| Romark Laboratories, LC | $121.02 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $119.59 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $736.10 | 6 | AstraZeneca Pharmaceuticals LP ($366.86) |
| 2022 | $672.36 | 6 | AstraZeneca Pharmaceuticals LP ($461.18) |
| 2021 | $485.35 | 4 | AstraZeneca Pharmaceuticals LP ($485.35) |
| 2020 | $345.05 | 3 | AstraZeneca Pharmaceuticals LP ($230.06) |
| 2019 | $761.48 | 7 | AbbVie, Inc. ($298.17) |
| 2018 | $1,136 | 12 | AbbVie, Inc. ($392.54) |
| 2017 | $453.42 | 7 | AbbVie, Inc. ($242.25) |
All Payment Transactions
45 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $121.71 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $125.70 | General |
| Category: Pulmonology | ||||||
| 05/09/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Respiratory | ||||||
| 05/09/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Inflammation | ||||||
| 04/20/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 02/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $120.03 | General |
| Category: Respiratory | ||||||
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 08/24/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $116.33 | General |
| Category: Respiratory | ||||||
| 08/24/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $116.33 | General |
| Category: Inflammation | ||||||
| 05/25/2022 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $94.85 | General |
| Category: Respiratory | ||||||
| 05/25/2022 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $94.85 | General |
| Category: Inflammation | ||||||
| 05/05/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 10/28/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 06/03/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 05/18/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 02/23/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $110.35 | General |
| Category: Respiratory | ||||||
| 11/17/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $105.06 | General |
| Category: Respiratory | ||||||
| 09/30/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 02/20/2020 | Nabriva Therapeutics, plc | Xenleta (Drug) | Food and Beverage | In-kind items and services | $114.99 | General |
| Category: Antibiotic | ||||||
| 09/19/2019 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Anemia | ||||||
| 07/10/2019 | Romark Laboratories, LC | Alinia (Drug), Alinia, Alinia | Food and Beverage | Cash or cash equivalent | $121.02 | General |
| Category: Gastroenterology | ||||||
| 06/05/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/28/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $98.17 | General |
| Category: Endocrinology | ||||||
| 04/29/2019 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $117.29 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/19/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: Virology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 187 | 392 | $35,465 | $23,332 |
| 2022 | 12 | 381 | 790 | $72,665 | $46,000 |
| 2021 | 12 | 365 | 727 | $62,620 | $39,547 |
| 2020 | 13 | 517 | 1,033 | $97,955 | $62,071 |
Total Patients
1,450
Total Services
2,942
Medicare Billing
$170,951
Procedure Codes
45
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 88 | $8,360 | $5,359 | 64.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 22 | 31 | $5,425 | $3,945 | 72.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 19 | 45 | $4,500 | $3,528 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 35 | 64 | $3,840 | $2,728 | 71.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 13 | 52 | $4,680 | $2,691 | 57.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 22 | 26 | $2,860 | $2,126 | 74.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 15 | 15 | $2,250 | $1,664 | 73.9% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 37 | 71 | $3,550 | $1,290 | 36.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 34 | 134 | $13,400 | $10,566 | 78.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 172 | $16,340 | $9,496 | 58.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 45 | 67 | $11,725 | $9,001 | 76.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 35 | 52 | $5,720 | $4,125 | 72.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 60 | 100 | $6,000 | $3,756 | 62.6% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 23 | 78 | $7,020 | $3,362 | 47.9% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 13 | 16 | $2,400 | $1,826 | 76.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $2,600 | $1,741 | 67.0% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 57 | 97 | $4,850 | $1,688 | 34.8% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 18 | 18 | $540.00 | $169.44 | 31.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 18 | 18 | $1,350 | $145.28 | 10.8% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 18 | 18 | $720.00 | $126.04 | 17.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 170 | $10,200 | $6,743 | 66.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 84 | $8,400 | $6,718 | 80.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 47 | $8,225 | $6,357 | 77.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 35 | 135 | $12,150 | $6,164 | 50.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 79 | $7,505 | $4,454 | 59.3% |
About Dr. Stephen Moore, MD
Dr. Stephen Moore, MD is a Pulmonary Disease healthcare provider based in Middletown, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083681076.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Moore, MD has received a total of $4,590 in payments from pharmaceutical and medical device companies, with $736.10 received in 2023. These payments were reported across 45 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($4,590).
As a Medicare-enrolled provider, Moore has provided services to 1,450 Medicare beneficiaries, totaling 2,942 services with total Medicare billing of $170,951. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Middletown, OH
- Active Since 03/08/2006
- Last Updated 05/15/2008
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083681076
Products in Payments
- BREZTRI (Drug) $855.38
- Creon (Drug) $739.63
- TEZSPIRE (Biological) $666.02
- INJECTAFER (Drug) $362.40
- BREZTRI AEROSPHERE (Drug) $230.06
- Mavyret (Drug) $193.33
- XIFAXAN (Drug) $129.60
- Prolastin-C Liquid (Biological) $125.70
- BREATHTEK (Device) $125.00
- AREXVY (Drug) $121.71
- Alinia (Drug) $121.02
- ZINPLAVA (Biological) $119.59
- XELJANZ (Drug) $117.29
- XARELTO (Drug) $117.18
- Xenleta (Drug) $114.99
- ZENPEP (Drug) $112.65
- TRULANCE (Drug) $100.00
- RELISTOR (Drug) $78.90
- Trulance (Drug) $22.40
- Donnatal (Drug) $12.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Middletown
Maryann Park, M.d, M.D
Pulmonary Disease — Payments: $47,541
Pulmonary Disease $47,541
David Shiu, Do, DO
Pulmonary Disease — Payments: $6,660
Pulmonary Disease $6,660
Dr. Janpreet Mokha, M.d, M.D
Pulmonary Disease — Payments: $1,085
Pulmonary Disease $1,085
Dr. Matthew Michaels, D.o, D.O
Pulmonary Disease — Payments: $221.67
Pulmonary Disease $221.67
Haitham Nsour, Md, MD
Pulmonary Disease — Payments: $50.41
Pulmonary Disease $50.41
Raymond Schoonmaker, M.d, M.D
Pulmonary Disease — Payments: $13.89
Pulmonary Disease $13.89